ÄÜÅÙÃ÷ »ó¼¼º¸±â
I see ¹ÙÀÌ¿ÀÀǾàÇ°


I see ¹ÙÀÌ¿ÀÀǾàÇ°

I see ¹ÙÀÌ¿ÀÀǾàÇ°

Àú | À¯ÆäÀÌÆÛ

Ãâ°£ÀÏ
2022-11-29
ÆÄÀÏÆ÷¸Ë
ePub
¿ë·®
35 M
Áö¿ø±â±â
PC½º¸¶Æ®ÆùÅÂºí¸´PC
ÇöȲ
½Åû °Ç¼ö : 0 °Ç
°£·« ½Åû ¸Þ¼¼Áö
ÄÜÅÙÃ÷ ¼Ò°³
¸ñÂ÷
ÇÑÁÙ¼­Æò

ÄÜÅÙÃ÷ ¼Ò°³

- ¹ÙÀÌ¿ÀÀǾàÇ° °³¹ß ¹× »ý»ê¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Àü°ø Áö½Ä¸¦ ´ã¾Ò½À´Ï´Ù.
- ¹ÙÀÌ¿ÀÀǾàÇ°¿¡ ´ëÇÑ ÀüüÀûÀÎ °³³ä°ú °³¹ß °úÁ¤À» ¹è¿ï ¼ö ÀÖ½À´Ï´Ù.
- Æ÷°ýÀûÀÎ ³»¿ëÀ» ´ã°í ÀÖÀ¸¸ç, ±âÃÊ °úÇп¡ ±âº»ÀûÀÎ ÀÌÇØ°¡ ÀÖ´Â ºÐÀ̳ª °ü·Ã Àü°øÀÚ¿¡°Ô Ãßõµå¸³´Ï´Ù.

¸ñÂ÷

1. ¹ÙÀÌ¿ÀÀǾàÇ°
Summary 1
¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ Á¤ÀÇ
¹ÙÀÌ¿ÀÀǾàÇ° ½ÃÀå
´Ü¹éÁú°ú PTM
¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ PTM
¹ÙÀÌ¿ÀÀǾàÇ°°ú Omics
¹ÙÀÌ¿À½Ã¹Ð·¯
¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ ÀÎÇã°¡ °úÁ¤
- ¹ÙÀÌ¿Àº£ÅÍ
- ÀÇ·á º¸Çè
2. ´Ü¹éÁú ±¸Á¶
Summary 2
´Ü¹éÁúÀÇ Á¾·ù¿Í ¿ªÇÒ
´Ü¹éÁúÀÇ Folding
´Ü¹éÁúÀÇ Interaction
´Ü¹éÁúÀÇ Structure
- Proteinogenic amino acid
- Absolute(R/S) & Relative(L/D) Configuration
3. ´Ü¹éÁú ºÐ¼®
Summary 3
Gel Electrophoresis
Size-exclusion Chromatography
Peptide Sequencing
Structure Information
Activity-based Assay
Protein Structure Prediction
- ElectrophoresisÀÇ ¿ø¸®
- Cryo-EM
4. ´Ü¹éÁú º¯¼º
Summary 4
´Ü¹éÁúÀÇ ¹°¸®Àû º¯¼º ¿øÀÎ
´Ü¹éÁúÀÇ È­ÇÐÀû º¯¼º ¿øÀÎ
´Ü¹éÁúÀÇ º¯¼º ¿ø¸® #1 - Deamidation
´Ü¹éÁúÀÇ º¯¼º ¿ø¸® #2 - Oxidation-Reduction
´Ü¹éÁúÀÇ º¯¼º ¿ø¸® #3 - Covalent Aggregation/ Proteolysis/ Physical Alteration
- Disulfide Formation
- Folding and Refolding
- Affinity Tag Technology
- Maillard Reaction
- Solid-phase Peptide Synthesis
- Chaperone
5. ´Ü¹éÁú PTM
Summary 5
¹ÙÀÌ¿ÀÀǾàÇ°°ú PTM
PTM Á¾·ù #1
PTM Á¾·ù #2
Glycosylation
Glycosylated Protein ºÐ¼®
Glycan ºÐ¼®
- Acylation
- Detection of other PTM with MS
- Difficulties of glycopeptide analysis
- Glycosylation in cancer
6. Áú·®ºÐ¼®±â
Summary 6
Áú·®ºÐ¼®±â¶õ?
ÀÌ¿ÂÈ­(Ionization) ¹æ¹ý
Soft Ionization
Mass analyzer #1
Mass analyzer #2
Tandem-MS & Peptide ºÐ¼®
´Ù¾çÇÑ Áú·®ºÐ¼®±â Á¾·ù
7. Áú·®ºÐ¼®±â ´Ü¹éÁú ºÐ¼®¹ý
Summary 7
Analysis of Intact Protein
Tryptic Digestion / In-gel Digestion
Nano LC and Nano Spray
Quantification with MS
- Resolution & Accuracy
- Áú·®(mass)ÀÇ Á¾·ù
8. ÀüÀÓ»ó½ÃÇè
Summary 8
¾à¹°À¯ÀüÇÐ (Pharmacogentics)
¾à¸®ÇÐ (Pharmacology)
µ¶¼º (Toxicity)
Protein immunogenecity
Improvement of strategy
- Fate of Biopharmaceuticals
- Pharmacogenetics vs. Pharmacogenomics
9. ¾à¹° Àü´Þ
Summary 9
Delivery Method
Oral Delivery
Parenteral Delivery (Injection)
Pulmonary and Nasal Delivery
10. Host & Process
Summary 10
Host #1 Escherichia coli
Host #2 Yeast
Host #3 Insect
Host #4 Plant
Host #5 Animal
Biopharmaceutical Production Process
Cultivation Methods
- Solid Fermentation
- Stock Preparation
- Exotocin and Endotoxin
- Methylation and Restriction
11. Downstream Process
Summary 11
Downstream Process
Cell Disruption
Removal of Insolubles
Isolation of Biopharmaceuticals
Purification
Finishing
- Immunoprecipitation
- Lectins and Protein A
12. ¹ÙÀÌ¿ÀÀǾàÇ° Á¾·ù
Summary 12
- Cytocines
- Interferon
- Interleukins
- Tumor Necrosis Factor ¥á (TNF-¥á)
- Haematopoietic Growth Factors (EPO)
- Growth Factor
- Insulin
- Monoclonal Antibody
- Vaccine
- Gene Therapy
- Antisense
- Aptamer
- Blood Product
- Therapeutic Enzymes
- Adjuvants
- Colony Stimulating Factors (CSF)
- Thrombolytic Agents
- Vascular Endotherlial Growth Factor (VEGF)
- Human Epidermal Growth Factor Receptor 2 (HER2)
- Epidermal Growth Factor (EGF)
Âü°í¹®Çå
ÆÇ±Ç ÆäÀÌÁö
Ç¥ÁöÆäÀÌÁö